Add like
Add dislike
Add to saved papers

Synthesis and reactivity of a cyclopentadienyl-indenyl ligand ring-coupled by a chiral bridge derived from ethyl (S)-(-) lactate.

In order to prepare a new unsymmetrical chiral ligand, C9H7CH(CH3)CH2C5H5, with an indenyl moiety connected to a cyclopentadienyl unit by a chiral ethylene bridge, we reacted the optically active tosylate 4, derived from ethyl (S)-(-) lactate, with LiCp. The only product resulting from this reaction was an optically active spirocyclopropane 6 obtained with a high diastereoselectivity (81.8% de). We also observed that, when the reduction of the ethyl indene lactate 2 was realized with an excess of LiAlH4 in Et2O under reflux, spirocyclopropane 6 was obtained in high yield with the same diastereoselectivity. When tosylate 4 was reacted with MgCp2, in place of LiCp, ligand 5 was obtained in good yield as a mixture of two double-bond isomers of the Cp unit. Ligand 5 was fully structurally characterized after conversion into transition monometallic complexes such as C9H7CH(CH3)CH2η(5)-C5H4Mo(CO)3Me 7 and C9H7CH(CH3)CH2η(5)-C5H4Rh(COD) 9, in which the indene moiety was kept intact due to the difference in reactivity of the indenyl moiety with respect to the cyclopentadienyl unit. An attempt to prepare a heterobimetallic complex from the sodium indenide salt of 7 and [RhCl(COD)]2, afforded a rhodium cyclopentadienyl complex 9, resulting from a metal exchange reaction with loss of the molybdenum part initially coordinated to the Cp unit, and conservation of the optical purity. An homobimetallic rhodium complex 10 could be prepared by deprotonation of ligand 5 with TlOEt, followed by quenching with [RhCl(COD)]2. The bis-rhodium complex 10 is obtained as a mixture of two diastereoisomers 10a and 10b with respect to the planar chirality of the indenyl ring system, with a good diastereoisomeric excess de = 70%. The structures of both complexes 9 and major (pS)-diastereoisomer 10a were determined by single crystal X-ray diffraction.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app